Biotech Buzz

LinkedInnewsletter · by Robert Naughton

Breakthroughs, Business, and Big Moves – This Week’s Global Highlights

Investigate Sign in to visit
Audience
Not shown publicly
We show a dash rather than guess
Publishing
Every two weeks
5 posts indexed in the last 90 days
Last post
Oct 28, 2026
4 days ago
Likely audience
Pharmaceutical executives
Inferred from post content

Biotech Buzz is a LinkedIn newsletter by Robert Naughton covering Clinical trial results, Biopharmaceuticals and Oncology. NewsletterFIT indexed 5 posts from it in the last 90 days, most recently on Oct 28, 2026.

Topics

Recent posts

  • Anthropic Bought…
  • Gilead's Pill…
  • Novartis Bets…
  • Europe's Pharma…
  • The Antibody…

Sponsors detected

No sponsored posts detected in the last 180 days of indexed posts.

Detected automatically from posts marked as sponsored. Detection can miss or misread placements.

See the full picture on Biotech Buzz

Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.

Start 7-day Pro trial

Similar newsletters

Ranked by how many topics they share with Biotech Buzz.

  • CTA Weekly Update—

    LinkedInEvery two weeks · last post 10 days ago

    Likely audience: Healthcare investors

    3 shared topics

  • Dr. Mercola's Censored Library (Private Membership)317K subscribers

    SubstackWeekly · last post today

    Likely audience: Immunologists and researchers

    1 shared topic

  • COVID Chronicles28K subscribers

    SubstackMonthly or less · last post 24 days ago

    Likely audience: Policy analysts

    1 shared topic

  • Repurposed Drugs: Powers & Possibilities24K subscribers

    SubstackEvery two weeks · last post 18 days ago

    Likely audience: Public health officials

    1 shared topic

  • Where Tech Meets Bio12K subscribers

    SubstackEvery two weeks · last post 10 days ago

    Likely audience: Venture capitalists

    1 shared topic

  • Dr. Michael Okun on Parkinson's & Brain Health11K subscribers

    SubstackMonthly or less · last post 21 days ago

    Likely audience: Patients with Parkinson's disease

    1 shared topic

  • Biotech Blueprint7K subscribers

    SubstackEvery two weeks · last post 17 days ago

    Likely audience: Biotech investors

    1 shared topic

  • Michael Halassa2K subscribers

    SubstackEvery two weeks · last post 24 days ago

    Likely audience: cognitive scientists

    1 shared topic

Compiled from public pages · refreshed Nov 2, 2026 · How NewsletterFIT collects and labels data